Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • No warning letters matched by name
Inspections 0 0 OAI
Recalls 64 0 Class I (0%)
Warning letters 0 None on file
510(k) clearances 0 None on file

Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical has 64 FDA recalls, 0 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical" is on file. FDA has published 4 Form 483s for Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical.

What these totals cover: FDA records filed under the name "Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical".

Latest recall
D-0935-2020 · Class II · Jan 15, 2020

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls64Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections0Nov 17, 2026Newest record Nov 9, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical: FDA recall records per year

2017: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 63 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202500000
202400000
202300000
202200000
202100000
2020000630
201900000
201800000
201700010

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical Form 483s

4 Form 483s published by FDA.

DateDocumentFEI
Dec 19, 2019 · Document on fda.gov Amended 4833013341563
Mar 21, 2018 · Document on fda.gov 4833013341563
May 24, 2017 · Document on fda.gov 4833013341563
May 24, 2017 · Document on fda.gov 4833013341563

A Form 483 lists the observations FDA investigators made at the end of an inspection. FDA publishes some Form 483s in its reading room, and each date links to that document. Read the observations with the FDA 483 search.

Recent recalls

64 recall records from Jul 12, 2017 to Jan 15, 2020. Showing the 20 most recent. View all 64 recall records

NumberClassProductDate
D-0935-2020Class IIAlprostadil (prostaglandin E1)150 MCG/ML Injectable, For Intracavernosal Use, Freeze, 2.5 mL…Jan 15, 2020
D-0956-2020Class IIHuman Chorionic Gonadotropin (hCG) Injection, HCG [10ML] 1000 IU/ML INJECTABLE, For IM, SC Use…Jan 15, 2020
D-0966-2020Class IIMethylcobalamin Injection, METHYLCOBALAMIN [CD] 10MG/100MG/ML INJECTABLE, For IV, IM, SC Use, 30 mL…Jan 15, 2020
D-0982-2020Class IISuper MIC Injection, SUPER MIC* INJECTABLE, Vitamin Complex, For IM Use, 30 mL Multi-dose Vial, Rx…Jan 15, 2020
D-0946-2020Class IICalcium Chloride Injection, For IM Use, Refrigerate, Shake Well, 30 mL Multi-dose Vial, Rx only…Jan 15, 2020
D-0947-2020Class IICoenzyme Q10 Injection,COENZYME Q-10 20MG/ML OIL INJ SOLN, For IM Use, 10 mL Multi-dose Vial, Rx…Jan 15, 2020
D-0989-2020Class IITriamcinolone Diacetate Injectable Suspension, TRIAMCINOLONE Diacetate [10ML] CMC 10MG/ML INJ SUSP…Jan 15, 2020
D-0975-2020Class IIMIC-PLUS Injection, Vitamin Complex, MIC-COMBO* 25MG/50MG/50MG/1MG/20MG/5MG/ML INJECTABLE, For IM…Jan 15, 2020
D-0934-2020Class IIAlprostadil/Papaverine Hydrochloride/Phentolamine Mesylate/Atropine Sulfate Injection, 60 mcg/30…Jan 15, 2020
D-0994-2020Class IIZinc Chloride Injection, ZINC CHLORIDE 10MG/ML INJECTABLE, For IV, IM Use, 30 mL Multi-dose Vial…Jan 15, 2020
D-0978-2020Class IINicotinamide Adenine Dinucleotide (PF) Injection, NICOTINAMIDE ADENINE DINUCLEOTIDE (PF) 20 MG/ML…Jan 15, 2020
D-0959-2020Class IIArginine Hydrochloride Injection, L-ARGININE HCL 100MG/ML INJECTABLE, For IV, IM Use, 30 mL…Jan 15, 2020
D-0940-2020Class IIAscorbiX (Buffered C) Injection, Ascorbix (50ML) 500MG/ML Injectable, For IV, IM, SC Use…Jan 15, 2020
D-0985-2020Class IITestosterone Cypionate/Progesterone Injection, TESTOSTERONE CYP/PROGESTERONE [2ML] 200MG/2.5MG/ML…Jan 15, 2020
D-0958-2020Class IIHydroxyprogesterone Caproate Injection, HYDROXYPROGESTERONE CAPROATE [4ML] 250 MG/ML INJECTABLE, For…Jan 15, 2020
D-0976-2020Class IIMitomycin-C (PF) Irrigation Solution, MITOMYCIN-C (PF) 0.5 MG/ML PF SYRINGE, For Intravesicular Use…Jan 15, 2020
D-0960-2020Class IIPolyoxyl Lauryl Ether (Polidocanol) Injection, LAURETH-9 (POLIDOCANOL) 5% INJECTABLE, For IV Use, 30…Jan 15, 2020
D-0936-2020Class IIAlprostadil (prostaglandin E1) 80 MCG/ML Injectable, For Intracavernosal Use, Freeze, 2.5 mL…Jan 15, 2020
D-0941-2020Class IIB-COMPLEX 110 INJECTABLE, For IV, IM, SC Use, Refrigerate, 30 mL Multi-dose Vial, Rx only, Axia…Jan 15, 2020
D-0943-2020Class IIBETAMETHASONE ACETATE/BETAMETHASONE (PF) Injectable Suspension, Betamethasone Acetate/Betamethasone…Jan 15, 2020

Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical and the FDA: common questions

Has Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical received an FDA warning letter?

No FDA warning letter addressed to the name "Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical received an FDA Form 483?

FDA has published 4 Form 483s for Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical in its reading room, the most recent dated Dec 19, 2019. FDA publishes some Form 483s, not all of them.

Has Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical had an FDA recall?

Yes. Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical has 64 FDA recalls on record. The most recent started Jan 15, 2020.

Need more than this page shows? Ask about Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.